Here, we report that the loss of skeletal muscle IPMK (henceforth referred to as MKO) disrupts insulin sensitivity and lipid utilization, leading to increased body weight, glucose intolerance, and reduced exercise tolerance. This evidence concerns the gene INS and Glucose intolerance.